Neurobiological effects of bisphenol A may be mediated by somatostatin subtype 3 receptors in some regions of the developing rat brain.
Considerable attention has been focused on environmental disruptors such as the xenoestrogen bisphenol A, which influences reproductive, developmental, and cognitive activities through its interaction with specific neuromediating systems in an estrogen-like fashion. In the present study, the effects of this xenoestrogen proved to be preferentially directed toward hypothalamic and extrahypothalamic somatostatin receptor subtype 3, which displayed a higher binding affinity of its specific nonpeptide agonist L-796-778 than that of L-779-976 (subtype 2). One type of action, with respect to animals treated with vehicle alone, consisted of a very strong (p < 0.001) decrease of somatostatin receptor subtype 3 mRNA levels in layer V of the frontoparietal cortex of adult rats (Sprague-Dawley) after transplacental and lactational exposure to bisphenol A (400 microg/kg/day). Similarly, such treatment in 7-day-old rats was responsible for a very strong reduction of the subtype 3 mRNA levels in the hypothalamic periventricular nuclei and a strong (p < 0.01) increase of the subtype 3 mRNA levels in the ventromedial nuclei. Moreover, even greater upregulated and downregulated activities were reported when subtype 3 mRNA levels were determined in the presence of receptor agonists specific for distinct alpha GABA(A) receptor subunits (alpha(1,5)). The predominant effects of bisphenol A on somatostatin receptor subtype 3 mRNA levels occurring in an alpha GABA(A) subunit-dependent manner tend to suggest the early modulatory importance of this environmental disruptor on cross-talking mechanisms that are implicated in the plasticity of neural circuits, with consequential influence on neuroendocrine/sociosexual behaviors.
Facciolo
Rosa Maria
RM
Comparative Neuroanatomy Laboratory of Ecology Department, University of Calabria, Arcavacata di Rende-Cosenza, Italy. rm.facciolo@unical.it
Madeo
Maria
M
Alò
Raffaella
R
Canonaco
Marcello
M
Dessì-Fulgheri
Francesco
F
D000395:Air Pollutants, Occupational / Q000633:toxicity; D000577:Amides / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001559:Benzhydryl Compounds; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004968:Estrogens, Non-Steroidal / Q000633:toxicity*; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology; D007774:Lactation / Q000187:drug effects; D018811:Maternal Exposure; D009578:Nitrobenzenes / Q000494:pharmacology; D038081:Organogenesis; D010636:Phenols / Q000633:toxicity*; D011247:Pregnancy; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism; D017481:Receptors, Somatostatin / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D013004:Somatostatin / Q000819:agonists; D000098826:Bisphenol A Compounds
D000395:Air Pollutants, Occupational; D000577:Amides; D001559:Benzhydryl Compounds; D004968:Estrogens, Non-Steroidal; D007211:Indoles; D009578:Nitrobenzenes; D010636:Phenols; D012333:RNA, Messenger; D011963:Receptors, GABA-A; D017481:Receptors, Somatostatin; D013004:Somatostatin; C121854:L 779976; C429627:L796778; C103631:somatostatin receptor 3; C006780:bisphenol A; D000098826:Bisphenol A Compounds